ABPI reveals 10% increase in HCP payment disclosure

08:27 EDT 30 Jun 2017 | Pharmafile

The headline news from the ABPI’s press conference on Disclosure UK was that healthcare professionals’ (HCPs) disclosure of payments for collaboration with the pharmaceutical industry was up 10% from the previous year. The annual update to its release of data on industry-wide disclosure figures also showed a marked increase in payments between the industry and HCPs, with a rise of 25%.

read more

Original Article: ABPI reveals 10% increase in HCP payment disclosure


More From BioPortfolio on "ABPI reveals 10% increase in HCP payment disclosure"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...